Mid-Atlantic BioTherapeutics
About:
Mid-Atlantic BioTherapeutics is a Clinical-stage Pharmaceutical Company.
Website: https://mabt.us/
Top Investors: SMITM Capital Markets
Description:
Mid-Atlantic BioTherapeutics they are focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. They are actively addressing the growing antibiotic resistance problems and creating a revolutionary treatment paradigm for viral diseases (e.g., the Tamiflu alternative for influenza), emerging infectious diseases, and biodefense.
Total Funding Amount:
$5M
Headquarters Location:
Doylestown, Pennsylvania, United States
Founded Date:
2011-01-01
Founders:
Number of Employees:
Last Funding Date:
2024-06-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai